- Home
- LUNG vs EOD Comparison
LUNG vs EOD Comparison
Compare LUNG & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- EOD
- Stock Information
- Founded
- LUNG 1995
- EOD 2007
- Country
- LUNG United States
- EOD United States
- Employees
- LUNG N/A
- EOD N/A
- Industry
- LUNG Industrial Specialties
- EOD Investment Managers
- Sector
- LUNG Health Care
- EOD Finance
- Exchange
- LUNG Nasdaq
- EOD Nasdaq
- Market Cap
- LUNG 256.3M
- EOD 214.9M
- IPO Year
- LUNG 2020
- EOD N/A
- Fundamental
- Price
- LUNG $6.36
- EOD $5.04
- Analyst Decision
- LUNG Buy
- EOD
- Analyst Count
- LUNG 6
- EOD 0
- Target Price
- LUNG $11.92
- EOD N/A
- AVG Volume (30 Days)
- LUNG 214.3K
- EOD 118.1K
- Earning Date
- LUNG 02-19-2025
- EOD 01-01-0001
- Dividend Yield
- LUNG N/A
- EOD 9.28%
- EPS Growth
- LUNG N/A
- EOD N/A
- EPS
- LUNG N/A
- EOD N/A
- Revenue
- LUNG $79,302,000.00
- EOD N/A
- Revenue This Year
- LUNG $22.26
- EOD N/A
- Revenue Next Year
- LUNG $18.72
- EOD N/A
- P/E Ratio
- LUNG N/A
- EOD N/A
- Revenue Growth
- LUNG 22.34
- EOD N/A
- 52 Week Low
- LUNG $5.46
- EOD $3.73
- 52 Week High
- LUNG $14.84
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- LUNG 41.35
- EOD 61.39
- Support Level
- LUNG $6.24
- EOD $4.77
- Resistance Level
- LUNG $7.27
- EOD $4.93
- Average True Range (ATR)
- LUNG 0.39
- EOD 0.08
- MACD
- LUNG -0.06
- EOD 0.02
- Stochastic Oscillator
- LUNG 2.52
- EOD 93.33
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.